BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, December 17, 2025
See today's BioWorld Asia
Home
» Other news to note for May 3, 2022
To read the full story,
subscribe
or
sign in
.
Other news to note for May 3, 2022
May 3, 2022
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Acuitas, Adge, Aethlon Medical, Beijing Zhifei Lvzhu, Bioarctic, Biocytogen, Cyan, Daiichi Sankyo, Eisai, Fujifilm Toyama, GC, Hansoh, Healion, Immune, Incyte, Intravacc, Ionova Life Science, Maruho, Merck & Co., Merck KGaA, Pharmabcine, Silence, Statera, Sumitomo, Taimed Biologics, Theratechnologies, Vigeneron, Wuxi Advanced Therapies.
BioWorld Asia
Briefs
Other news to note